POH03 Beyond the Surface: Innovations and Cutting-Edge Therapies in Non-Melanoma Skin Cancer
DESCRIPTION
This session will explore the latest advancements and cutting-edge therapeutic techniques in the diagnosis, prognostication, and treatment of non-melanoma skin cancers. Topics will include chemoprophylaxis and field therapy updates, prognostication and surveillance, developments in imaging and artificial intelligence, and systemic and intralesional therapies. Attendees will gain insights into the clinical application of these techniques and their potential to improve patient outcomes.
LEARNING OBJECTIVES
Examine the latest advancements in diagnostic tools and prognostic markers for non-melanoma skin cancers, and assess how these innovations can improve early detection and individualized treatment plans.
Identify and evaluate the latest advancements in therapeutic techniques for the treatment of non-melanoma skin cancer.
Discuss the future directions and potential applications of emerging technologies in the management and treatment of non-melanoma skin cancers.
SCHEDULE
7:30 AM
Chemoprophylaxis and field therapy updates
Kathryn Shahwan, MD, FAAD
7:42 AM
Prognostication and surveillance
David R. Carr, MD, MPH, FAAD
7:54 AM
Innovations in imaging and artificial intelligence
Erica Lee, MD, FAAD
8:06 AM
Systemic and intralesional therapies
Mary L. Stevenson, MD, FAAD
8:18 AM
Q&A
DIRECTOR
Kathryn Shahwan, MD, FAAD
The Ohio State University
CO-DIRECTOR
David R. Carr, MD, MPH, FAAD
The Ohio State University College of Medicine
SPEAKERS
Erica Lee, MD, FAAD
Mary L. Stevenson, MD, FAAD
DISCLOSURES
David R. Carr, MD, MPH, FAAD
Regeneron – Investigator(No Compensation Received);
Erica Lee, MD, FAAD
UpToDate, Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights);
Kathryn Shahwan, MD, FAAD
No financial relationships exist with ineligible companies.
Mary L. Stevenson, MD, FAAD
No financial relationships exist with ineligible companies.